Teva Pharmaceutical Industries' quest to acquire Mylan NV could wind up in a Dutch court - Pittsburgh Business Times
Teva, Maker of Generic Drugs, Bids $40 Billion to Acquire Its Rival Mylan - The New York Times
Teva Pharmaceutical Industries Ltd. - Our generic medicines generate savings for healthcare systems around the world and increase patients' access to quality, affordable medicines. In 2020, savings from Teva's generic medicines in
A logo sign outside of a facility occupied by Teva Pharmaceutical Industries in Haarlem, Netherlands on October 5, 2015 Stock Photo - Alamy
Neil Hoskings - Head of HR Europe - Teva Pharmaceuticals | LinkedIn